New York, NY -- (SBWIRE) -- 12/22/2014 -- Insulin is a naturally occurring hormone that maintains blood sugar levels in the body. Insulin also helps in the proper functioning of all cellular and physiological activities. Insulin is secreted by pancreas. The improper functioning of pancreas leads to diabetes. Diabetes is a disease characterized by high blood sugar levels. People with diabetes are prescribed with insulin to maintain the sugar level in the blood. There are various types of insulin used to treat diabetes such as short acting insulin, rapid acting insulin, intermediate acting insulin and long acting insulin. Insulin is delivered with the help of syringe, insulin pump and injection pen.

Buy Full Report:
http://www.persistencemarketresearch.com/market-research/human-insulin-market.asp

North America dominates the global market for human insulin due to large number of aging population and increasing healthcare cost. Asia is expected to show high growth rates in the next five years in global human insulin market. China and India are expected to be the fastest growing human insulin markets in Asia-Pacific region. Some of the key driving forces for human insulin market in emerging countries are high prevalence rate of insulin and low price of human insulin.

In recent times there is increased use of human insulin due to increasing diabetic population. Increasing prevalence of lifestyle associated disorders, increasing demand of biosimilar drugs and increasing demand for insulin analog are some of the key factors driving the growth for global human insulin market. In addition, increasing government initiatives is also fuelling the growth of global human insulin market. However, high manufacturing cost and complexity, and stringent regulatory requirements are some of the major factors restraining the growth for global human insulin market.

Introduction of insulin pump and pen device would lead to growth in the global human insulin market. In addition, pipeline products of insulin would develop opportunities for the global human insulin market. However, massive clinical trials for approval and requirement of complex infrastructure for manufacturing could lead a challenge for global human insulin market. Some of the trends for global human insulin market are collaborations and agreements. Some of the major companies operating in the global human insulin market are Biocon, Novo Nordisk, Eli Lily, Sembiosys, Julphar Pharmaceuticals, GSK, Wockhardt and Sanofi Aventis.

Request Full Toc:
http://www.persistencemarketresearch.com/toc/3308

Key points covered in the report:

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation

North America
Europe
Asia
RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.

Visit our blog at http://persistencemarketresearchblog.wordpress.com/

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.